{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T04:51:04Z","timestamp":1782967864371,"version":"3.54.5"},"reference-count":48,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100027563","name":"VanEd","doi-asserted-by":"publisher","award":["VA HSR RES 13-457"],"award-info":[{"award-number":["VA HSR RES 13-457"]}],"id":[{"id":"10.13039\/100027563","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015534","name":"Office of Patient Care Services, Department of Veterans Affairs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015534","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019592","name":"Veterans Administration Medical Center, Yale School of Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019592","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013017","name":"Vanderbilt University Medical Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013017","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.jtha.2024.07.011","type":"journal-article","created":{"date-parts":[[2024,7,22]],"date-time":"2024-07-22T11:54:08Z","timestamp":1721649248000},"page":"3107-3124","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Evaluating the safety and effectiveness of direct oral anticoagulants compared with warfarin in very elderly patients with atrial fibrillation with and without low bodyweight"],"prefix":"10.1016","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7257-3463","authenticated-orcid":false,"given":"Tanvi","family":"Patil","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salihah","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davida","family":"Eppes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aliza","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nabil","family":"Jarmukli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtha.2024.07.011_bib1","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1093\/eurheartj\/ehi825","article-title":"Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study","volume":"27","author":"Heeringa","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jtha.2024.07.011_bib2","doi-asserted-by":"crossref","first-page":"213","DOI":"10.2147\/CLEP.S47385","article-title":"Epidemiology of atrial fibrillation: European perspective","volume":"6","author":"Zoni-Berisso","year":"2014","journal-title":"Clin Epidemiol"},{"key":"10.1016\/j.jtha.2024.07.011_bib3","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.jacc.2016.11.061","article-title":"The changing landscape for stroke prevention in AF: finding from the GLORIA-AF registry phase 2","volume":"69","author":"Huisman","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jtha.2024.07.011_bib4","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.amjmed.2017.10.036","article-title":"Clinical outcomes and history of fall in patients with atrial fibrillation treated with oral anticoagulation: insights from the ARISTOTLE trial","volume":"131","author":"Rao","year":"2018","journal-title":"Am J Med"},{"key":"10.1016\/j.jtha.2024.07.011_bib5","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1161\/CIRCULATIONAHA.115.018544","article-title":"Polypharmacy and the efficacy and safety of rivaroxaban versus warfarin in the prevention of stroke in patients with nonvalvular atrial fibrillation","volume":"133","author":"Piccini","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.jtha.2024.07.011_bib6","doi-asserted-by":"crossref","first-page":"i2868","DOI":"10.1136\/bmj.i2868","article-title":"Polypharmacy and effects of apixaban versus warfarin in patients with atrial fibrillation: post hoc analysis of the ARISTOTLE trial","volume":"353","author":"Jaspers Focks","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.jtha.2024.07.011_bib7","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1093\/ageing\/afn293","article-title":"The impact of frailty on the utilisation of antithrombotic therapy in older patients with atrial fibrillation","volume":"38","author":"Perera","year":"2009","journal-title":"Age Ageing"},{"key":"10.1016\/j.jtha.2024.07.011_bib8","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1111\/ggi.13058","article-title":"Clinical frailty is independently associated with non-prescription of anticoagulants in older patients with atrial fibrillation","volume":"17","author":"Induruwa","year":"2017","journal-title":"Geriatr Gerontol Int"},{"key":"10.1016\/j.jtha.2024.07.011_bib9","first-page":"169","article-title":"The effect of bleeding risk and frailty status on anticoagulation patterns in octogenarians with atrial fibrillation: the FRAIL-AF study","volume":"32","author":"Lefebvre","year":"2016","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.jtha.2024.07.011_bib10","article-title":"Thromboembolic risk, bleeding outcomes and effect of different antithrombotic strategies in very elderly patients with atrial fibrillation: a sub-analysis from the PREFER in AF (PREvention oF Thromboembolic Events-European Registry in Atrial Fibrillation)","volume":"6","author":"Patti","year":"2017","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jtha.2024.07.011_bib11","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.chest.2018.07.040","article-title":"Antithrombotic therapy for atrial fibrillation: CHEST guideline and expert panel report","volume":"154","author":"Lip","year":"2018","journal-title":"Chest"},{"key":"10.1016\/j.jtha.2024.07.011_bib12","doi-asserted-by":"crossref","first-page":"e125","DOI":"10.1161\/CIR.0000000000000665","volume":"140","author":"January","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.jtha.2024.07.011_bib13","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","article-title":"2020 ESC guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS)","volume":"42","author":"Hindricks","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jtha.2024.07.011_bib14","doi-asserted-by":"crossref","first-page":"325","DOI":"10.2147\/VHRM.S121661","article-title":"Evaluation of bleeding in patients receiving direct oral anticoagulants","volume":"13","author":"Hellenbart","year":"2017","journal-title":"Vasc Health Risk Manag"},{"key":"10.1016\/j.jtha.2024.07.011_bib15","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1007\/s00228-017-2296-1","article-title":"Trends in use of warfarin and direct oral anticoagulants in atrial fibrillation in Norway, 2010 to 2015","volume":"73","author":"Kjerpeseth","year":"2017","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.jtha.2024.07.011_bib16","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1182\/blood-2014-07-590323","article-title":"The impact of bleeding complications in patients receiving target-specific oral anticoagulants: a systematic review and meta-analysis","volume":"124","author":"Chai-Adisaksopha","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2024.07.011_bib17","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1007\/s00392-017-1102-5","article-title":"The non-vitamin K antagonist oral anticoagulants (NOACs) and extremes of body weight-a systematic literature review","volume":"106","author":"De Caterina","year":"2017","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/j.jtha.2024.07.011_bib18","article-title":"Efficacy and safety of edoxaban in elderly patients with atrial fibrillation in the ENGAGE AF-TIMI 48 trial","volume":"5","author":"Kato","year":"2016","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jtha.2024.07.011_bib19","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1093\/eurheartj\/ehu046","article-title":"Efficacy and safety of apixaban compared with warfarin according to age for stroke prevention in atrial fibrillation: observations from the ARISTOTLE trial","volume":"35","author":"Halvorsen","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jtha.2024.07.011_bib20","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.hrthm.2016.12.036","article-title":"Increased risk of major bleeding in underweight patients with atrial fibrillation who were prescribed non-vitamin K antagonist oral anticoagulants","volume":"14","author":"Park","year":"2017","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jtha.2024.07.011_bib21","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1016\/j.chest.2019.11.025","article-title":"Comparing the effectiveness and safety of nonvitamin K antagonist oral anticoagulants and warfarin in elderly asian patients with atrial fibrillation: a nationwide cohort study","volume":"157","author":"Chao","year":"2020","journal-title":"Chest"},{"key":"10.1016\/j.jtha.2024.07.011_bib22","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","article-title":"Dabigatran versus warfarin in patients with atrial fibrillation","volume":"361","author":"Connolly","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jtha.2024.07.011_bib23","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1001\/jamacardio.2016.1829","article-title":"Apixaban 5 mg twice daily and clinical outcomes in patients with atrial fibrillation and advanced age, low body weight, or high creatinine: a secondary analysis of a randomized clinical trial","volume":"1","author":"Alexander","year":"2016","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jtha.2024.07.011_bib24","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1111\/bcp.12114","article-title":"Effect of extremes of body weight on the pharmacokinetics, pharmacodynamics, safety and tolerability of apixaban in healthy subjects","volume":"76","author":"Upreti","year":"2013","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jtha.2024.07.011_bib25","doi-asserted-by":"crossref","DOI":"10.1111\/eci.13335","article-title":"Non-vitamin K vs vitamin K oral anticoagulants in patients aged > 80 year with atrial fibrillation and low body weight","volume":"50","author":"Russo","year":"2020","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.jtha.2024.07.011_bib26","article-title":"Identification of incident atrial fibrillation from electronic medical records","volume":"11","author":"Chamberlain","year":"2022","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jtha.2024.07.011_bib27","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1136\/bmj.39335.541782.AD","article-title":"Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"335","author":"von Elm","year":"2007","journal-title":"BMJ"},{"key":"10.1016\/j.jtha.2024.07.011_bib28","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ahj.2014.09.014","article-title":"Accuracy and validation of an automated electronic algorithm to identify patients with atrial fibrillation at risk for stroke","volume":"169","author":"Navar-Boggan","year":"2015","journal-title":"Am Heart J"},{"key":"10.1016\/j.jtha.2024.07.011_bib29","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1378\/chest.10-0134","article-title":"A\u00a0novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey","volume":"138","author":"Pisters","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.jtha.2024.07.011_bib30","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1097\/MLR.0000000000000729","article-title":"Development of a claims-based frailty indicator anchored to a well-established frailty phenotype","volume":"55","author":"Segal","year":"2017","journal-title":"Med Care"},{"key":"10.1016\/j.jtha.2024.07.011_bib31","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1093\/gerona\/glab071","article-title":"Updating and validating the U.S. Veterans Affairs Frailty Index: transitioning from ICD-9 to ICD-10","volume":"76","author":"Cheng","year":"2021","journal-title":"J\u00a0Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/j.jtha.2024.07.011_bib32","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1002\/pds.3674","article-title":"Measuring frailty using claims data for pharmacoepidemiologic studies of mortality in older adults: evidence and recommendations","volume":"23","author":"Kim","year":"2014","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.jtha.2024.07.011_bib33","first-page":"188","article-title":"Charlson Comorbidity Index: ICD-9 update and ICD-10 translation","volume":"12","author":"Glasheen","year":"2019","journal-title":"Am Health Drug Benefits"},{"key":"10.1016\/j.jtha.2024.07.011_bib34","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1055\/s-0038-1651587","article-title":"A\u00a0method to determine the optimal intensity of oral anticoagulant therapy","volume":"69","author":"Rosendaal","year":"1993","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.07.011_bib35","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1002\/pds.2109","article-title":"An automated database case definition for serious bleeding related to oral anticoagulant use","volume":"20","author":"Cunningham","year":"2011","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.jtha.2024.07.011_bib36","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0203599","article-title":"A\u00a0new model to predict major bleeding in patients with atrial fibrillation using warfarin or direct oral anticoagulants","volume":"13","author":"Claxton","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.jtha.2024.07.011_bib37","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1161\/01.STR.0000032240.28636.BD","article-title":"Validating administrative data in stroke research","volume":"33","author":"Tirschwell","year":"2002","journal-title":"Stroke"},{"key":"10.1016\/j.jtha.2024.07.011_bib38","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1002\/pds.2312","article-title":"A\u00a0systematic review of validated methods for identifying cerebrovascular accident or transient ischemic attack using administrative data","volume":"21","author":"Andrade","year":"2012","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.jtha.2024.07.011_bib39","first-page":"1211","article-title":"Preparing for the ICD-10-CM transition: automated methods for translating ICD codes in clinical phenotype definitions","volume":"4","author":"Fung","year":"2016","journal-title":"EGEMS (Wash DC)"},{"key":"10.1016\/j.jtha.2024.07.011_bib40","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1002\/pds.4563","article-title":"Early impact of the ICD-10-CM transition on selected health outcomes in 13 electronic health care databases in the United States","volume":"27","author":"Panozzo","year":"2018","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.jtha.2024.07.011_bib41","doi-asserted-by":"crossref","first-page":"297","DOI":"10.7326\/0003-4819-151-5-200909010-00003","article-title":"The net clinical benefit of warfarin anticoagulation in atrial fibrillation","volume":"151","author":"Singer","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jtha.2024.07.011_bib42","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jclinepi.2004.03.015","article-title":"A\u00a0Bayesian approach to evaluating net clinical benefit allowed for parameter uncertainty","volume":"58","author":"Sutton","year":"2005","journal-title":"J\u00a0Clin Epidemiol"},{"key":"10.1016\/j.jtha.2024.07.011_bib43","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.1524-4733.2009.00671.x","article-title":"Use of stabilized inverse propensity scores as weights to directly estimate relative risk and its confidence intervals","volume":"13","author":"Xu","year":"2010","journal-title":"Value Health"},{"key":"10.1016\/j.jtha.2024.07.011_bib44","doi-asserted-by":"crossref","first-page":"268","DOI":"10.7326\/M16-2607","article-title":"Sensitivity analysis in observational research: introducing the E-value","volume":"167","author":"VanderWeele","year":"2017","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jtha.2024.07.011_bib45","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1161\/CIRCULATIONAHA.121.056355","article-title":"Direct oral anticoagulants versus warfarin in patients with atrial fibrillation: patient-level network meta-analyses of randomized clinical trials with interaction testing by age and sex","volume":"145","author":"Carnicelli","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.jtha.2024.07.011_bib46","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.jacc.2018.11.051","article-title":"Direct oral anticoagulants in patients with nonvalvular atrial fibrillation and low body weight","volume":"73","author":"Lee","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jtha.2024.07.011_bib47","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1007\/s11239-013-1048-z","article-title":"Estimation of the impact of warfarin's time-in-therapeutic range on stroke and major bleeding rates and its influence on the medical cost avoidance associated with novel oral anticoagulant use-learnings from ARISTOTLE, ROCKET-AF, and RE-LY trials","volume":"38","author":"Amin","year":"2014","journal-title":"J\u00a0Thromb Thrombolysis"},{"key":"10.1016\/j.jtha.2024.07.011_bib48","doi-asserted-by":"crossref","first-page":"3488","DOI":"10.1161\/STROKEAHA.115.011139","article-title":"Rates and determinants of 5-year outcomes after atrial fibrillation-related stroke: a population study","volume":"46","author":"Hayden","year":"2015","journal-title":"Stroke"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783624004288?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783624004288?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T20:58:50Z","timestamp":1762030730000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783624004288"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":48,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["S1538783624004288"],"URL":"https:\/\/doi.org\/10.1016\/j.jtha.2024.07.011","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluating the safety and effectiveness of direct oral anticoagulants compared with warfarin in very elderly patients with atrial fibrillation with and without low bodyweight","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtha.2024.07.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc. on behalf of International Society on Thrombosis and Haemostasis.","name":"copyright","label":"Copyright"}]}}